Antibiotics to reduce post‐tonsillectomy morbidity

Scolaris Content Display Scolaris Content Display

Ir a:

Analysis 1.1

Comparison 1 Total secondary haemorrhage, Outcome 1 Number of patients with total secondary haemorrhage.

Analysis 2.1

Comparison 2 Significant secondary haemorrhage, Outcome 1 Number of patients with significant secondary haemorrhage.

Analysis 3.1

Comparison 3 Fever, Outcome 1 Number of patients with fever.

Analysis 4.1

Comparison 4 Adverse events, Outcome 1 Number of patients with adverse events or side effects.

Comparison 1. Total secondary haemorrhage

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number of patients with total secondary haemorrhage Show forest plot	7	567	Risk Ratio (M‐H, Random, 95% CI)	0.90 [0.56, 1.44]

Comparison 1. Total secondary haemorrhage

Comparison 2. Significant secondary haemorrhage

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number of patients with significant secondary haemorrhage Show forest plot	7	567	Risk Ratio (M‐H, Random, 95% CI)	0.49 [0.08, 3.11]

Comparison 2. Significant secondary haemorrhage

Comparison 3. Fever

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number of patients with fever Show forest plot	2	186	Risk Ratio (M‐H, Random, 95% CI)	0.63 [0.46, 0.85]

Comparison 3. Fever

Comparison 4. Adverse events

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number of patients with adverse events or side effects Show forest plot	4	282	Risk Ratio (M‐H, Random, 95% CI)	2.06 [0.68, 6.27]

Comparison 4. Adverse events